Short answer · Medically reviewed summary · Last updated: 2026-05-08
Adrenal Cortical Carcinoma (ACC) is diagnosed through a combination of biochemical hormone testing, cross-sectional imaging (CT or MRI), and histopathological analysis following surgical resection. Because Adrenal Cortical Carcinoma (ACC) is an extremely rare malignancy, diagnosis often involves a multidisciplinary team to distinguish it from benign adrenal adenomas. How is Adrenal Cortical Carcinoma (ACC) diagnosed step-by-step? The diagnostic pathway for Adrenal Cortical Carcinoma (ACC) usually begins when an adrenal mass is discovered incidentally or due to symptoms of hormone excess.
3 people with Adrenal Cortical Carcinoma (ACC) have shared their first-person experience on this question at DiseaseMaps.
Adrenal Cortical Carcinoma (ACC) is diagnosed through a combination of biochemical hormone testing, cross-sectional imaging (CT or MRI), and histopathological analysis following surgical resection. Because Adrenal Cortical Carcinoma (ACC) is an extremely rare malignancy, diagnosis often involves a multidisciplinary team to distinguish it from benign adrenal adenomas.
The diagnostic pathway for Adrenal Cortical Carcinoma (ACC) usually begins when an adrenal mass is discovered incidentally or due to symptoms of hormone excess. Clinicians follow a rigorous protocol to evaluate the tumor's function and malignant potential. Because many patients with Adrenal Cortical Carcinoma (ACC) experience a "diagnostic odyssey," it is common to see multiple specialists before arriving at a definitive conclusion. The diagnostic process typically includes:
Due to the complexity of the disease, diagnosis should be managed by an endocrinologist and a specialized surgeon (urologist or endocrine surgeon). A pathologist with specific expertise in adrenal tumors is also critical for accurate staging. If you feel your current team is unfamiliar with Adrenal Cortical Carcinoma (ACC), seeking a second opinion at a high-volume academic medical center is vital, as early, accurate diagnosis significantly impacts treatment outcomes.
Distinguishing Adrenal Cortical Carcinoma (ACC) from benign adrenal adenomas or pheochromocytomas is the primary challenge in differential diagnosis. Many adrenal incidentalomas are benign; however, Adrenal Cortical Carcinoma (ACC) is characterized by rapid growth and specific hormonal profiles. Genetic testing may also be recommended to rule out hereditary syndromes like Li-Fraumeni syndrome, which can predispose individuals to this condition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.